# The Impact of Body Mass Index on Clinical Characteristics and Treatment Outcomes in Endometrial Cancer Patients: A Comprehensive Analysis

## Authors

- Behzat Can ([ORCID](https://orcid.org/0000-0002-3797-8227)) — Diyarbakır Gazi Yaşargil Training and Research Hospital Department of Gyneacological Oncology, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 9, Issue 3 (2023), pages 145–151
- **Article type:** Original Article
- **Published online:** 2023-09-13
- **DOI:** [10.5455/umj.20230822070551](https://doi.org/10.5455/umj.20230822070551)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=166473
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/166473.pdf

## Abstract

Introduction: The study investigates the influence of Body Mass Index (BMI) on demographic and clinical characteristics, the choice of treatment modalities, and their potential impact on treatment response and prognosis in endometrial cancer. Materials and Methods: This retrospective cohort study analyzed individuals diagnosed with endometrial cancer who underwent gynecological surgical interventions. BMI was calculated as weight (kg) divided by height (m) squared and categorized into four subgroups: overweight (BMI 25-29.9), obesity class 1 (BMI 30-34.9), obesity class 2 (BMI 35-39.9), and obesity class 3 (BMI ≥40). Demographic and clinical data were extracted from medical records. Results: Menopausal status differed across subgroups (p=0.013), with obesity class 3 showing a higher proportion of premenopausal women. Diabetes mellitus prevalence was higher in obesity class 3 (p=0.044). The usage of radiotherapy, brachytherapy, chemotherapy, and radiochemotherapy were similar across subgroups, as were relapse rates. The most commonly performed surgery was TAH+BSO+PPLND across all subgroups, with the highest percentage in the obesity class 3 (68.4%). The distribution of surgery types showed no difference across BMI subgroups (p=0.569). Conclusion: Our study highlights the potential influence of BMI on menopausal status and surgical treatment strategies in endometrial cancer patients. The findings emphasize the importance of considering BMI in managing endometrial cancer, given the rising global prevalence of obesity.

## Keywords

BMI; endometrial cancer; treatment outcomes; surgical interventions

## How to cite

Can B. The Impact of Body Mass Index on Clinical Characteristics and Treatment Outcomes in Endometrial Cancer Patients: A Comprehensive Analysis. Ulutas Med J. 2023;9(3):145-151. doi:10.5455/umj.20230822070551

## References

1. Fink J, Seifert G, Blüher M, Fichtner-Feigl S, Marjanovic G. Obesity Surgery. Dtsch Arztebl Int. 2022;119(5):70-80.
2. Khanna D, Peltzer C, Kahar P, Parmar MS. Body Mass Index (BMI): A Screening Tool Analysis. Cureus. 2022;14(2):e22119. https://doi.org/10.7759/cureus.22119
3. Petersen Harrington S, Balmaceda J, Spoozak L, Jewell A, Fitzgerald-Wolff S. Higher baseline BMI and lower estimated median income associated with increasing BMI after endometrial cancer diagnosis. Gynecol Oncol Rep. 2022;44: 101123. https://doi.org/10.1016/j.gore.2022.101123
4. Eakin CM, Liao CI, Salani R, Cohen JG, Kapp DS, Chan JK. The association of obesity with type I uterine cancer-is this an oversimplification? Am J Obstet Gynecol. 2022;227(3): 538-9. https://doi.org/10.1016/j.ajog.2022.05.016
5. Bo LL, Wang YQ, Liu YY, Li XD, Zhou R, Wang JL. [Analyze of obesity indicators and effect of fertility preservation treatment in patients with endometrial atypical hyperplasia and early endometrial cancer]. Zhonghua Fu Chan Ke Za Zhi. 2022;57(10):767-74.
6. Anic K, Flohr F, Schmidt MW, Krajnak S, Schwab R, Schmidt M, et al. Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study. J Cancer Res Clin Oncol. 2023;149(4):1551-60. https://doi.org/10.1007/s00432-022-04038-6
7. Petersdorf K, Groettrup-Wolfers E, Overton PM, Seitz C, Schulze-Rath R. Endometrial hyperplasia in premenopausal women: A systematic review of incidence, prevalence, and risk factors. Eur J Obstet Gynecol Reprod Biol. 2022; 271:158-71. https://doi.org/10.1016/j.ejogrb.2022.02.015
8. Driver JA, Viswanathan AN. Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older. Gynecol Oncol. 2017;145(3):526-30. https://doi.org/10.1016/j.ygyno.2017.03.010
9. Belladelli F, Montorsi F, Martini A. Metabolic syndrome, obesity and cancer risk. Curr Opin Urol. 2022;32(6):594-7. https://doi.org/10.1097/mou.0000000000001041
10. Wiley RL, Urbauer DL, Nugent E, Gallegos J, Ramondetta L. Endometrial cancer patients understanding and interest in weight loss surgery. Gynecol Oncol. 2023;175:88-92. https://doi.org/10.1016/j.ygyno.2023.05.068
11. King L, Gajarawala S, McCrary MD. Endometrial cancer and obesity: Addressing the awkward silence. Jaapa. 2023;36(1):28-31. 151 77 Body Mass Index and Endometrial Cancer Behzat Can https://doi.org/10.1097/01.jaa.0000902884.01725.a3
12. Markowska A, Chudecka-Głaz A, Pityński K, Baranowski W, Markowska J, Sawicki W. Endometrial Cancer Management in Young Women. Cancers (Basel). 2022;14(8). https://doi.org/10.3390/cancers14081922
13. Agnew H, Kitson S, Crosbie EJ. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer. Cochrane Database Syst Rev. 2023;3(3):Cd012513. https://doi.org/10.1002/14651858.cd012513.pub3
14. Petersen Harrington S, Balmaceda J, Spoozak L, Jewell A, Fitzgerald-Wolff S. Higher baseline BMI and lower estimated median income is associated with increasing BMI after endometrial cancer diagnosis. Gynecol Oncol Rep. 2022;44(Suppl 1):101109. https://doi.org/10.1016/j.gore.2022.101109
15. van der Woude H, Hally KE, Currie MJ, Gasser O, Henry CE. Importance of the endometrial immune environment in endometrial cancer and associated therapies. Front Oncol. 2022;12:975201. https://doi.org/10.3389/fonc.2022.975201
16. Kokts-Porietis RL, Elmrayed S, Brenner DR, Friedenreich CM. Obesity and mortality among endometrial cancer survivors: A systematic review and meta-analysis. Obes Rev. 2021;22(12):e13337. https://doi.org/10.1111/obr.13337
17. Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 2012;126(2):176-9. https://doi.org/10.1016/j.ygyno.2012.04.013
18. Onstad MA, Schmandt RE, Lu KH. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J Clin Oncol. 2016;34(35):4225-30. https://doi.org/10.1200/jco.2016.69.4638
19. Gaballa K, Abdelkhalek M, Refky B, Gadelhak B, Aboelnaga EM, El-Beshbishi W. The Impact of Obesity on Surgical Complications and Disease Recurrence in Endometrial Cancer: A Retrospective Study of 267 Patients. Research in Oncology. 2020;16(1):11-4. https://doi.org/10.21608/resoncol.2020.23506.1089
20. Erkanli S, Kayaselçuk F, Bagis T, Kuşçu E. Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects. Eur J Gynaecol Oncol. 2006;27(4):401-4.
21. Bouwman F, Smits A, Lopes A, Das N, Pollard A, Massuger L, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature. Gynecol Oncol. 2015;139(2):369-76. https://doi.org/10.1016/j.ygyno.2015.09.020
22. Chen J, Ke K, Liu Z, Yang L, Wang L, Zhou J, et al. Body Mass Index and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies. Nutr Cancer. 2023;75(4):1051-64. https://doi.org/10.1080/01635581.2023.2180824